Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.

Autor: Krishnan T; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada., Safro M; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada., Furlanetto DM; Department of Radiology, Department of Surgical Oncology, Vancouver General Hospital, Vancouver, British Columbia, Canada., Gill S; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada., Solar Vasconcelos JP; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada., Stuart HC; Department of Radiology, Department of Surgical Oncology, Vancouver General Hospital, Vancouver, British Columbia, Canada., Martineau P; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada., Loree JM; Department of Medical Oncology, Department of Nuclear Medicine, BC Cancer Vancouver, Vancouver, British Columbia, Canada.

Publikováno v: Journal of neuroendocrinology [J Neuroendocrinol] 2024 Jan; Vol. 36 (1), pp. e13360. Date of Electronic Publication: 2023 Dec 13.